Microrna-21 antagonists and its target PDCD4 for use in the treatment of a glioma

The present invention embraces microRNA-21 antagonists and activators of Programmed Cell Death 4 for use in decreasing glial tumor cell proliferation and treating glioma.

Patents:
US 20,110,118,336

Inventor(s): GAUR ARTI [US]; ISRAEL MARK A [US]

Type of Offer: Licensing